Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

KK Shah Hospitals Ltd

BSE: 544013 · Diversified Consumer Services · 8 announcements

Share price
₹45.00
Market cap
₹30.64 Cr
Revenue (annual)
₹9.43 Cr
Net profit (annual)
₹-0.62 Cr
P/E (TTM)
-49.2×Sector 34.2×
Promoter holding
71.36%
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

11:08 IST BSE
Annual General Meeting

KK Shah Hospitals Annual General Meeting

KK Shah Hospitals Ltd announced the voting results for its Annual General Meeting held on August 18, 2026. All proposed resolutions were passed by shareholders.

14:09 IST BSE
Annual General Meeting

KK Shah Hospitals Annual General Meeting

KK Shah Hospitals Limited conducted its 4th Annual General Meeting on August 18, 2026. Shareholders considered the adoption of annual accounts and the re-appointment of directors.

14:39 IST BSE
Annual Report

KK Shah Hospitals Annual Report

KK Shah Hospitals Ltd has submitted its Annual Report for the financial year 2025-26 and the notice for its 4th Annual General Meeting.

19:05 IST BSE
Annual General Meeting

KK Shah Hospitals Annual General Meeting

KK Shah Hospitals Limited announced its board meeting outcome, which included the approval of the Director's Report and scheduling its 4th Annual General Meeting for August 2026.

13:08 IST BSE
Business Update

KK Shah Hospitals Business Update

KK Shah Hospitals installed a GE Revolution Evo 64‑slice cardiac CT scanner in Ratlam. A Siemens 1.5T MRI will be commissioned shortly, broadening diagnostic services.

18:10 IST BSE
Financial Results

KK Shah Hospitals Financial Results

KK Shah Hospitals reported FY2026 total revenue of ₹9.62 Crore. The board also appointed M/s Jayesh Chopra & Associates as internal auditors for FY2026-27.

Value
₹9.62 Cr
11:40 IST BSE
Board Meeting Date

KK Shah Hospitals Board Meeting Date

KK Shah Hospitals scheduled a Board Meeting for May 18, 2026. Directors will consider audited standalone financial results for the year ended March 2026.